小儿肺炎支原体肺炎的临床诊治研究

Clinical Diagnosis and Treatment of Mycoplasma Pneumoniae Pneumonia in Children

目的探讨小儿肺炎支原体肺炎的临床治疗方法及效果。方法选择2014年10月—2017年10月本院收治的120例小儿支原体肺炎患儿作为研究对象,将其随机分为对照组(60例)和观察组(60例)。在常规对症治疗基础上,对照组采用红霉素治疗,观察组采用阿奇霉素治疗,对比两组治疗效果及住院时间。结果观察组治疗总有效率(95.00%)高于对照组(78.33%),差异具有统计学意义(P<0.05)。观察组住院时间为(8.52±1.35)d,对照组为(11.03±2.17)d,组间数据对比,差异具有统计学意义(P<0.05)。结论小儿支原体肺炎积极采取对症治疗及阿奇霉素治疗,临床疗效可靠,抗感染效果良好。

Objective To discuss the clinical treatment and effect of mycoplasma pneumonia in children. Methods 120 cases of children with mycoplasma pneumonia in our hospital from October 2014 to October 2017 were randomly divided into the control group（60 cases） and the observation group（60 cases）. On the basis of routine symptomatic treatment, the control group was treated with erythromycin, and azithromycin was used in the observation group, and the treatment effect and the time of hospitalization were compared between the two groups. Results The total effective rate of treatment in the observation group（95.00%） was significantly higher than that of the control group（78.33%）, the difference was statistically significant（P 〈 0.05）. The time of hospitalization in the observation group was（8.52 ± 1.35） d, and the control group was（11.03 ± 2.17） d, the difference was statistically significant（P 〈 0.05）. Conclusion Mycoplasma pneumonia in children actively adopts symptomatic treatment and azithromycin treatment, and the clinical effect is reliable, the effect of anti-infection is good.